<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Zhou et al
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> showed that COVID-19 shares 79.5% sequence identity with SARS-CoV. It was then isolated from the BAL fluid of a critically ill patient and was found to be neutralized by sera from similarly infected patients. It was also confirmed that COVID-19 uses the same cell entry receptor, angiotensin-converting enzyme 2, as SARS-CoV, which is highly expressed in airway epithelial cells.
</p>
